Marín C,
Díaz-de-Valdés L, Conejeros C, Martínez R, Niklander S. Interventions for the
treatment of xerostomia: A randomized controlled clinical trial. J Clin Exp
Dent. 2021;13(2):e104-11.
doi:10.4317/jced.57924
https://doi.org/10.4317/jced.57924
___________
References
|
1.
Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a
cross-sectional study. Aust Dent J. 2011;56:290-5. |
|
|
|
|
|
2.
Ying Joanna ND, Thomson WM. Dry mouth - An overview. Singapore Dent J.
2015;36:12-7. |
|
|
|
|
|
3.
Ikebe K, Matsuda K, Morii K, Wada M, Hazeyama T, Nokubi T, et al. Impact of
dry mouth and hyposalivation on oral health-related quality of life of
elderly Japanese. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2007;103:216-22. |
|
|
|
|
|
4.
Gil-Montoya JA, Silvestre FJ, Barrios R, Silvestre-Rangil J. Treatment of
xerostomia and hyposalivation in the elderly: A systematic review. Med Oral
Patol Oral Cir Bucal. 2016;21:e355-66. |
|
|
|
|
|
5.
Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J.
2010;55:238-44; quiz 353. |
|
|
|
|
|
6.
Yuan A, Woo SB. Adverse drug events in the oral cavity. Oral Surg Oral Med
Oral Pathol Oral Radiol. 2015;119:35-47. |
|
|
|
|
|
7.
Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M. Risk
factors, hyposalivation and impact of xerostomia on oral health-related
quality of life. Braz Oral Res. 2017;31:e14. |
|
|
|
|
|
8.
Ohara Y, Hirano H, Yoshida H, Obuchi S, Ihara K, Fujiwara Y, et al.
Prevalence and factors associated with xerostomia and hyposalivation among
community-dwelling older people in Japan. Gerodontology. 2016;33:20-27. |
|
|
|
|
|
9.
van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability
of a xerostomia questionnaire and the association between xerostomia,
hyposalivation and medication use in a group of nursing home residents. Clin
Oral Investig. 2011;15:185-92. |
|
|
|
|
|
10.
Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of Various Etiologies:
A Review of the Literature. Adv Clin Exp Med. 2016;25:199-206. |
|
|
|
|
|
11.
Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev
Oral Biol Med. 2004;15:221-39. |
|
|
|
|
|
12.
Plemons JM, Al-Hashimi I, Marek CL; American Dental Association Council on
Scientific Affairs. Managing xerostomia and salivary gland hypofunction:
executive summary of a report from the American Dental Association Council on
Scientific Affairs. J Am Dent Assoc. 2014;145:867-73. |
|
|
|
|
|
13.
Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and
hyposalivation. Ther Clin Risk Manag. 2014;11:45-51. |
|
|
|
|
|
14.
Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R. Interventions
for the management of dry mouth: topical therapies. Cochrane Database Syst
Rev. 2011;(12):CD008934. |
|
|
|
|
|
15.
Niklander S, Fuentes F, Sanchez D, Araya V, Chiappini G, Martinez R, et al.
Impact of 1% malic acid spray on the oral health-related quality of life of
patients with xerostomia. J Oral Sci. 2018;60:278-84. |
|
|
|
|
|
16.
Murray Thomson W, Poulton R, Mark Broadbent J, Al-Kubaisy S. Xerostomia and
medications among 32-year-olds. Acta Odontol Scand. 2006;64:249-54. |
|
|
|
|
|
17.
Minicucci EM, Pires RB, Vieira RA, Miot HA, Sposto MR. Assessing the impact
of menopause on salivary flow and xerostomia. Aust Dent J. 2013;58:230-4. |
|
|
|
|
|
18.
Pai S, Ghezzi EM, Ship JA. Development of a Visual Analogue Scale
questionnaire for subjective assessment of salivary dysfunction. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 2001;91:311-6. |
|
|
|
|
|
19.
Lopez R, Baelum V. Spanish version of the Oral Health Impact Profile
(OHIP-Sp). BMC Oral Health. 2006;6:11. |
|
|
|
|
|
20.
Montero-Martín J, Bravo-Pérez M, Albaladejo-Martínez A, Hernández-Martín LA,
Rosel-Gallardo EM. Validation the Oral Health Impact Profile (OHIP-14sp) for
adults in Spain. Med Oral Patol Oral Cir Bucal. 2009;14:E44-50. PMid:19114956 |
|
|
|
|
|
21.
Navazesh M, Kumar SK; University of Southern California School of Dentistry.
Measuring salivary flow: challenges and opportunities. J Am Dent Assoc.
2008;139:35S-40S. |
|
|
|
|
|
22.
Thomson WM, Lawrence HP, Broadbent JM, Poulton R. The impact of xerostomia on
oral-health-related quality of life among younger adults. Health Qual Life
Outcomes. 2006;4:86. |
|
|
|
|
|
23.
Thomson WM. Dry mouth and older people. Aust Dent J. 2015;60:54-63. |
|
|
|
|
|
24.
Ahmad MS, Bhayat A, Zafar MS, Al-Samadani KH. The Impact of Hyposalivation on
Quality of Life (QoL) and Oral Health in the Aging Population of Al Madinah
Al Munawarrah. Int J Environ Res Public Health. 2017;14:445. |
|
|
|
|
|
25.
Furness S, Bryan G, McMillan R, Birchenough S, Worthington HV. Interventions
for the management of dry mouth: non-pharmacological interventions. Cochrane
Database Syst Rev. 2013;2013:CD009603. PMid:23996155 |
|
|
|
|
|
26.
Silvestre-Donat FJ, Miralles-Jordá L, Martínez-Mihi V. Protocol for the
clinical management of dry mouth. Med Oral. 2004;9:273-9. PMid:15292864 |
|
|
|
|
|
27.
Gómez-Moreno G, Aguilar-Salvatierra A, Guardia J, Uribe-Marioni A,
Cabrera-Ayala M, Delgado-Ruiz RA, et al. The efficacy of a topical sialogogue
spray containing 1% malic acid in patients with antidepressant-induced dry
mouth: a double-blind, randomized clinical trial. Depress Anxiety.
2013;30:137-42. |
|
|
|
|
|
28.
Gómez-Moreno G, Guardia J, Aguilar-Salvatierra A, Cabrera-Ayala M,
Maté-Sánchez de-Val JE, Calvo-Guirado JL. Effectiveness of malic acid 1% in
patients with xerostomia induced by antihypertensive drugs. Med Oral Patol
Oral Cir Bucal. 2013;18:e49-55. |
|
|
|
|
|
29.
Ship JA, McCutcheon JA, Spivakovsky S, Kerr AR. Safety and effectiveness of
topical dry mouth products containing olive oil, betaine, and xylitol in
reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil.
2007;34:724-32. |
|
|
|
|
|
30.
Martín M, Marín A, López M, Liñán O, Alvarenga F, Büchser D, Cerezo L. Products
based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia.
Rep Pract Oncol Radiother. 2017;22:71-6. |
|